Tasmanian families would have greater access to healthcare services through local pharmacies under a state election promise ...

Treatments such as muscle relaxant medications for high-tone pelvic floor muscles can help, but if the tightness is due to an ...

Frequent trips to the bathroom can be an early warning sign of an enlarged prostate, also known as Benign Prostatic ...

Urogen Pharma Ltd. plans to launch its new product July 1 after the firm overcame a decidedly mixed FDA advisory panel meeting to nail down approval June 12 of Zusduri (mitomycin, formerly known as ...

THOMASVILLE — Archbold is now offering Aquablation therapy with the new HYDROS™ Robotic System, the next-generation platform ...

Dermatologists are well positioned to treat vulvovaginal disorders common among menopausal women, including itch, yet ...

The FDA has approved Zusduri (mitomycin intravesical solution) to treat adults with recurrent, low-grade, intermediate-risk NMIBC.

The FDA approved intravesical mitomycin in non–muscle-invasive bladder cancer as an nonsurgical alternative to transurethral ...

Recurrent urinary tract infections and potentially abnormal Pap smears are among the consequences of untreated GSM.

Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder ...

Recently, to my surprise, I came down with bladder cancer. I am a healthy 66-year-old man who is 5 feet, 11 inches tall, 215 pounds, and a lifelong ...

The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk ...